Skip to content
OpenCapital
Get started

Bankwell Financial Group BWFG Trial Loan Modifications

Other financials

Income statement

See full
Revenue$30.2M+28.2%
Net income$11.3M+63.7%
EPS (diluted)$1.41+62.1%

Balance sheet

See full
Cash & equivalents$217.9M-28.5%
Total debt$11.0M-8.7%
Total equity$311.9M+13.3%
Total assets$3.4B+6.0%

Cash flow

See full
Operating cash flow$7.7M+96.8%
CapEx$470.0K+385%
Free cash flow$7.3M+89.5%

Valuation

See full
Market cap$462.21M+66.9%
P/E11.7×-9.8×
P/S4×+0.9×

Profitability

See full
Net margin34.4%+19.9pp
FCF margin26.6%-1.5pp

Returns & leverage

See full
Return on equity13.5%+8.7pp
Debt / equity0×0.0×

Where this comes from

Reported directly by Bankwell Financial Group in its filing.

Tagged under the XBRL concept us-gaap:FinancingReceivableModificationsRecordedInvestment.

The official record: Bankwell Financial Group’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bankwell Financial Group's trial loan modifications.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bankwell Financial Group's trial loan modifications?
Bankwell Financial Group (BWFG) reported trial loan modifications of $300K in Q4 2025.
How has Bankwell Financial Group's trial loan modifications changed year-over-year?
Bankwell Financial Group's trial loan modifications decreased by 92.5% year-over-year, from $4M to $300K.
What is the long-term trend for Bankwell Financial Group's trial loan modifications?
Over 5 years (2020 to 2025), Bankwell Financial Group's trial loan modifications has grown at a -49.5% compound annual growth rate (CAGR), from $9.1M to $300K.